| A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma ( | Phase III | rekrutiert |
| A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Followin | Phase III | rekrutiert |
| A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014) | Phase II | rekrutiert |
| A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Smal | Phase I / Phase II | rekrutiert |
| A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Trea | Phase I / Phase II | rekrutiert |
| A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/I | Phase II | rekrutiert |
| A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475 | Phase III | rekrutiert |
| A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorub | Phase II | rekrutiert |
| A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis | Phase II | rekrutiert |
| A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed | Phase III | rekrutiert |
| A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease | Phase III | rekrutiert |
| A Comparison of Two Psychotherapy Programs in Persistently Depressed Treatment-Resistant Inpatie | ohne Phasenangabe | rekrutiert |
| A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Scle | — | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa | — | rekrutiert |
| A Non-interventional, Prospective Study With Benralizumab | — | rekrutiert |
| A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy | Phase I / Phase II | rekrutiert |
| A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia | Phase I | rekrutiert |
| A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Throm | Phase III | rekrutiert |
| A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Even | Phase III | rekrutiert |
| A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antib | Phase III | rekrutiert |
| A Study in Children and, Adults With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treat | — | rekrutiert |
| A Study of AZD0120 in Autoimmune Diseases | Phase I | rekrutiert |
| A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Ch | Phase III | rekrutiert |
| A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Diseas | Phase II | rekrutiert |
| A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone | Phase III | rekrutiert |
| A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Cro | Phase III | rekrutiert |
| A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal S | Phase III | rekrutiert |
| A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps | Phase III | rekrutiert |
| A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy | Phase III | rekrutiert |
| A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and | Phase III | rekrutiert |
| A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or L | Phase II | rekrutiert |
| A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate | Phase II | rekrutiert |
| A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Pati | Phase III | rekrutiert |
| A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease | Phase III | rekrutiert |
| A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemot | Phase III | rekrutiert |
| A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzuma | Phase II / Phase III | rekrutiert |
| A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin | Phase III | rekrutiert |
| A Study to Assess Effectiveness and Efficiency of VNS Therapy in Patients With Difficult to Trea | — | rekrutiert |
| A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart ( | Phase III | rekrutiert |
| A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking | Phase III | rekrutiert |
| A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) | Phase III | rekrutiert |
| A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of The | Phase III | rekrutiert |
| A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + | Phase III | rekrutiert |
| A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hosp | Phase III | rekrutiert |
| A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in P | Phase III | rekrutiert |
| A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants Wi | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Mo | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Mul | Phase II | rekrutiert |
| A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Mar | Phase III | rekrutiert |
| A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination | Phase I / Phase II | rekrutiert |
| A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Level | — | rekrutiert |
| A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease | Phase II | rekrutiert |
| A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotocl | Phase III | rekrutiert |
| A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in | Phase I / Phase II | rekrutiert |
| A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult | Phase III | rekrutiert |
| A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 | Phase II | rekrutiert |
| A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Fa | Phase III | rekrutiert |
| A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-ob | Phase II | rekrutiert |
| AI Based Muscular Ultrasound to Assess Intensive Care Unit-acquired Weakness | — | rekrutiert |
| AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate | Phase III | rekrutiert |
| Abbott Structural Heart Device Registry | — | rekrutiert |
| Acquisition of Cardiac Function Parameters in MRI and Echocardiography in Patients With Ethyltox | ohne Phasenangabe | rekrutiert |
| Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL | Phase III | rekrutiert |
| Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leuka | Phase II / Phase III | rekrutiert |
| An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-ter | Phase III | rekrutiert |
| Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer | ohne Phasenangabe | rekrutiert |
| Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study | — | rekrutiert |
| Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG | Phase III | rekrutiert |
| Asciminib Roll-over Study | Phase IV | rekrutiert |
| Association of Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With Immunomodulation an | — | rekrutiert |
| CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitu | Phase III | rekrutiert |
| Cardiac Biomarkers for the Quantification of Myocardial Damage After Cardiac Surgery | — | rekrutiert |
| Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL) | — | rekrutiert |
| Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients | Phase III | rekrutiert |
| Cohort Study on Plant-based Diets (COPLANT Study) | — | rekrutiert |
| Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute My | Phase I / Phase II | rekrutiert |
| Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lym | Phase II | rekrutiert |
| Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracra | ohne Phasenangabe | rekrutiert |
| Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Ol | Phase II | rekrutiert |
| Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women | ohne Phasenangabe | rekrutiert |
| Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI | ohne Phasenangabe | rekrutiert |
| CytOSorb TreatMent Of Critically Ill PatientS Registry | — | rekrutiert |
| Dazucorilant in Patients With Amyotrophic Lateral Sclerosis | Phase II | rekrutiert |
| Deep Brain Stimulation (DBS) Retrospective Outcomes Study | — | rekrutiert |
| EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagl | Phase III | rekrutiert |
| Effects of Continued Administration of Empagliflozin in Patients With Heart Failure on Active SG | Phase III | rekrutiert |
| Efficacy of Add-on Plasma Exchange As an Adjunctive Strategy Against Septic Shock | ohne Phasenangabe | rekrutiert |
| Endometrial Cancer Lymphadenectomy Trial | ohne Phasenangabe | rekrutiert |
| European Larynx Organ Preservation Study (ELOS) [MK-3475-C44] | Phase II | rekrutiert |
| Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FAS | Phase III | rekrutiert |
| Fosfomycin I.v. for Treatment of Severely Infected Patients | — | rekrutiert |
| Functional Impact of Acute Respiratory Viral Infections in Older Adults | — | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| German Dementia Registry | — | rekrutiert |
| German MPN-Registry for BCR-ABL 1-Negative Myeloid Neoplasms (Study Group Ulm) | — | rekrutiert |
| HRS-AKI Treatment With TIPS in Patients With Cirrhosis | ohne Phasenangabe | rekrutiert |
| ITP Registry and Accompanying Biospecimen Collection | — | rekrutiert |
| Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multi | Phase III | rekrutiert |
| Improved Management of Patients With Recent-Onset Stable Chest Pain | ohne Phasenangabe | rekrutiert |
| International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lym | Phase III | rekrutiert |
| International HIT-MED Registry (I-HIT-MED) | — | rekrutiert |
| JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC | Phase III | rekrutiert |
| KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generali | Phase II / Phase III | rekrutiert |
| LEOPARD Training and Validation Data Collection Study | — | rekrutiert |
| LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2 | Phase III | rekrutiert |
| Left Atrial Appendage Occlusion Versus Novel Oral Anticoagulation for Stroke Prevention in Atria | ohne Phasenangabe | rekrutiert |
| Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdi | — | rekrutiert |
| Living Donor Liver Transplantation With Two Stage Hepatectomy for Patients With Isolated, Irrese | ohne Phasenangabe | rekrutiert |
| Long-term Follow-up of Children Born in the PETN Studies | — | rekrutiert |
| Low INR to Minimize Bleeding With Mechanical Valves Trial | Phase III | rekrutiert |
| Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and | Phase III | rekrutiert |
| Mentalization-based Treatment Versus Bona-fide Treatment for Patients With Borderline Personalit | ohne Phasenangabe | rekrutiert |
| Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT | Phase III | rekrutiert |
| Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial Collection | — | rekrutiert |
| Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in A | Phase III | rekrutiert |
| Nivolumab in Children and Adults With Nasopharyngeal Carcinoma | Phase II | rekrutiert |
| OP2C : Prialt® Observatory in Clinical Practice | — | rekrutiert |
| Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours U | — | rekrutiert |
| One-Month DAPT in CABG Patients | Phase III | rekrutiert |
| Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sH | Phase II / Phase III | rekrutiert |
| PAIN OUT: Improvement in Postoperative PAIN OUTcome | — | rekrutiert |
| PROCARE - PROstate Cancer Real World Evidence Registry | — | rekrutiert |
| PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and | — | rekrutiert |
| Pan Tumor Rollover Study | Phase II | rekrutiert |
| Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Asci | Phase III | rekrutiert |
| Pharmacologic Treatment Augmentation in Chronic Depression | Phase II | rekrutiert |
| Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic | Phase II | rekrutiert |
| Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial | Phase II / Phase III | rekrutiert |
| Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothel | Phase II / Phase III | rekrutiert |
| Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenal | Phase III | rekrutiert |
| Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mID | Phase II | rekrutiert |
| Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prosta | Phase I / Phase II | rekrutiert |
| Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - POR | Phase III | rekrutiert |
| Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation | ohne Phasenangabe | rekrutiert |
| Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody | Phase II | rekrutiert |
| Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS | Phase III | rekrutiert |
| Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed C | — | rekrutiert |
| Product Surveillance Registry | — | rekrutiert |
| Prospective Evaluation of Ivosidenib Maintenance Following Allogeneic Stem Cell Transplantation | Phase II | rekrutiert |
| Randomization of Single vs Multiple Arterial Grafts | ohne Phasenangabe | rekrutiert |
| Randomized Comparison of Skeletonized Versus Pedicled Left Internal Thoracic Artery | ohne Phasenangabe | rekrutiert |
| Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blin | Phase II | rekrutiert |
| Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia | Phase III | rekrutiert |
| Rapid Point-of-care Bacteriuria and Microbial Susceptibility for Women With Suspected Uncomplica | — | rekrutiert |
| Real World Data Collection on the INSPIRIS RESILIA Aortic Valve | — | rekrutiert |
| Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Pro | — | rekrutiert |
| Registry Study of Assistive Devices, Medicines and Healthcare Measures in ALS, SMA and Other Neu | — | rekrutiert |
| Retrospective Analysis of Performance and Treatment Data Collected for Genius SleddFlux Filter, | — | rekrutiert |
| Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS) | Phase II | rekrutiert |
| SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access | — | rekrutiert |
| STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease | Phase III | rekrutiert |
| Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome | Phase II / Phase III | rekrutiert |
| Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral | Phase IV | rekrutiert |
| Screening for Disorders of Lipid Metabolism and Familial Hyperlipidemia in Children and Adolesce | ohne Phasenangabe | rekrutiert |
| Serum Bile Acid Profiles in Patients With Intrahepatic Cholestasis of Pregnancy | — | rekrutiert |
| Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy | — | rekrutiert |
| Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants | Phase I | rekrutiert |
| Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced | Phase III | rekrutiert |
| Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN | Phase III | rekrutiert |
| Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/ | Phase I / Phase II | rekrutiert |
| Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoim | Phase II | rekrutiert |
| Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent | Phase II | rekrutiert |
| Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Folli | Phase III | rekrutiert |
| Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Wh | Phase III | rekrutiert |
| Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003) | Phase III | rekrutiert |
| Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid L | Phase III | rekrutiert |
| Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or | Phase II | rekrutiert |
| Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in | Phase III | rekrutiert |
| Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With | Phase I | rekrutiert |
| Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With | — | rekrutiert |
| Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Co | Phase I / Phase II | rekrutiert |
| Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL | Phase II | rekrutiert |
| Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-r | Phase IV | rekrutiert |
| The AFteR Registry - Follow-up Study to Monitor the Efficacy and Safety of the Occlutech AFR in | — | rekrutiert |
| The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis | Phase III | rekrutiert |
| The DefiPace Study | — | rekrutiert |
| The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial | Phase III | rekrutiert |
| The German ADPKD Tolvaptan Treatment Registry | — | rekrutiert |
| The Gut Microbiome - Source of Sepsis and Novel Target in Intensive Care Units? | — | rekrutiert |
| The Pancreatic Enzymes After Gastrectomy Trial | Phase III | rekrutiert |
| Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells V | Phase III | rekrutiert |
| Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM AL | Phase III | rekrutiert |
| Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephali | Phase II | rekrutiert |
| Trifluridine/Tipiracil + Fruquintinib Versus Trifluridine/Tipiracil Alone for Metastatic Oeso-ga | Phase III | rekrutiert |
| TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs | Phase I / Phase II | rekrutiert |
| Ultra-high-caloric, Fatty Diet in ALS | ohne Phasenangabe | rekrutiert |
| Ultrahypofractionated, Adaptive Radiation Therapy of Prostate Cancer | — | rekrutiert |
| Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) | Phase I / Phase II | rekrutiert |
| Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metast | Phase II | rekrutiert |